Inclusion Criteria:
* Diagnosis of classical ADA-SCID based on:
* A proven defective adenosine deaminase (ADA) gene as defined by direct sequencing of patient DNA.
* T-cell immune deficiency defined as one or more of the following: CD3+ autologous T cells \< 300/ul, or less than 50% of normal value for in vitro mitogen stimulation, or absent proliferation in vitro to antigens.
* With severe infections, including but not limited to: pneumonitis; protracted diarrhea requiring total parenteral nutrition; infection with herpes viruses or adenovirus or fungus; disseminated BCG infection.
* No cytogenetic abnormalities (medullary karyotype) and no detection of main rearrangements associated with acute leukemia of children.
* No prior allogeneic stem cell transplantation.
* Life expectancy ≥ 2 months.
* Negative for HIV infection.
* Written, informed consent obtained prior to any study-specific procedures.
Exclusion Criteria:
* None
View Inclusion and Exclusion Criteria at ClinicalTrials.gov